The cytotoxicity of 40-leucine-avarone, amino derivative of the sponge Dysidea avara secondary metabolite avarone, was evaluated by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazoliumbromide assay in vitro against seven human solid tumours for the first time. The compound tested induced dose-dependent cytotoxic response in all cancer cells showing better activity towards the lung A-549 and colon HT-29 cell lines (IC50 7.40mM and 9.62mM, respectively) than towards the breast adenocarcinoma ER positive MCF-7 and ERnegativeMDA-MB-231 cells (IC50 11.64mMand 17.31mM, respectively), the prostate adenocarcinoma PC-3 and epiteloid cervix carcinoma HeLa cells (IC50 14.24mM and 15.54mM, respectively). No toxicity was found towards the foetal lung fibroblast MRC-5 cell line at the concentrations used. According to experimental data obtained, the sesquiterpenoid quinone structure of avarone may inspire development of new drug-like substances with improved cytotoxicity on lung cancer in humans
Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4'-leucine-avarone
Iodice C;Tommonaro G;
2014
Abstract
The cytotoxicity of 40-leucine-avarone, amino derivative of the sponge Dysidea avara secondary metabolite avarone, was evaluated by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazoliumbromide assay in vitro against seven human solid tumours for the first time. The compound tested induced dose-dependent cytotoxic response in all cancer cells showing better activity towards the lung A-549 and colon HT-29 cell lines (IC50 7.40mM and 9.62mM, respectively) than towards the breast adenocarcinoma ER positive MCF-7 and ERnegativeMDA-MB-231 cells (IC50 11.64mMand 17.31mM, respectively), the prostate adenocarcinoma PC-3 and epiteloid cervix carcinoma HeLa cells (IC50 14.24mM and 15.54mM, respectively). No toxicity was found towards the foetal lung fibroblast MRC-5 cell line at the concentrations used. According to experimental data obtained, the sesquiterpenoid quinone structure of avarone may inspire development of new drug-like substances with improved cytotoxicity on lung cancer in humansI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
